Catalyst Pharmaceutical
CPRX
CPRX
69 hedge funds and large institutions have $93.7M invested in Catalyst Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% more funds holding
Funds holding: 50 → 69 (+19)
10.01% more ownership
Funds ownership: 30.5% → 40.51% (+10%)
Holders
69
Holding in Top 10
–
Calls
$1.08M
Puts
$109K
Top Buyers
| 1 | +$8.38M | |
| 2 | +$4.02M | |
| 3 | +$2.46M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.91M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.9M |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$1.71M | |
| 3 | -$316K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$184K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$110K |